Literature DB >> 311682

Inhibition of the lectin-induced mitogenic response of thymocytes by glycolipids.

E E Lengle, R Krishnaraj, R G Kemp.   

Abstract

Exogenous gangliosides at concentrations found in serum inhibit the concanavalin A- (Con A) induced mitogenic response of mouse thymocytes. Of four gangliosides tested, the trisialoganglioside, GT1, was the most potent inhibitor. Ceramides, cerebrosides, and sialic acid were not inhibitory at any concentration tested. The inhibition by gangliosides was not due to interference with Con A binding as shown by direct binding studies with [3H]acetyl-Con A nor was it due to a nonspecific killing effect. Thymocytes exposed to a ganglioside concentration 5 times that required to inhibit mitogenesis were still capable of excluding trypan blue up to 44 hr after ganglioside addition. Furthermore, ganglioside inhibition could be reversed by washing the cells 4 hr after addition of the glycolipid. A productive interaction with Con A occurs in the presence of ganglioside as shown by a Con A-induced increase in carbohydrate metabolism. However, uridine and thymidine incorporation are inhibited by the presence of ganglioside. Complete inhibition could be achieved if the glycolipid were added as late as 24 to 28 hr after the Con A in a 48-hr mitogenic assay. The results are discussed in light of recent findings that elevated levels of gangliosides are found in in the sera of tumor-bearing animals, and it is suggested that gangliosides shed by tumor cells could be involved in the generalized immunosuppression observed in such animals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311682

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Activation of human T lymphocytes by ganglioside-containing liposomes.

Authors:  K Yanagihara; E Kato; S Hitomi; J Sunamoto; H Wada
Journal:  Glycoconj J       Date:  1999-01       Impact factor: 2.916

Review 2.  Brain and thymus gangliosides: their molecular diversity and its biological implications and a dynamic annular model for their function in cell surface membranes.

Authors:  Y Nagai; M Iwamori
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

3.  Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2.

Authors:  R Li; D Gage; R McKallip; S Ladisch
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

4.  Sensitization against brain gangliosides after therapeutic swine brain implantation in a multiple sclerosis patient.

Authors:  S Knorr-Held; W Brendel; H Kiefer; G Paal; B U von Specht
Journal:  J Neurol       Date:  1986-02       Impact factor: 4.849

5.  Ceramide structure predicts tumor ganglioside immunosuppressive activity.

Authors:  S Ladisch; R Li; E Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Gangliosides shed by tumor cells enhance tumor formation in mice.

Authors:  S Ladisch; S Kitada; E F Hays
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  [T-lymphocyte activation. Studies on the function of mediator proteins (author's transl)].

Authors:  E Köttgen; H A Fabricius; R Stahn; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

8.  Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro.

Authors:  S Ladisch; L Ulsh; B Gillard; C Wong
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Potentiation of interleukin-2 production and its binding by monoclonal antibodies to the gangliosides GD3 and GD2.

Authors:  S Schibeci; P Hersey; D Cheresh
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

10.  Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.

Authors:  Ana M H Vázquez; Nely Rodrèguez-Zhurbenko; Ana M V López
Journal:  Front Oncol       Date:  2012-11-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.